Friday September 3, 2010
Health
AimsBio-Health
The early detection of serious diseases is the most important factor underlying successful treatments. Diagnostic laboratories are in dire need of tools to improve the reliability of their assays and to decrease the time required to obtain results.
The core technology of AimsBio-Health is rapid, low-cost diagnostic kits based on unique bioreporter technologies. Our first product will be a kit that measures amino acid levels in blood serum, and our pipeline for new diagnostics focuses on speed, cost, and accuracy using novel bioreporter technologies. The market for medical diagnostic kits is expected to reach $18.5 B by 2013.
